231 – 240 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Activities of daily living - Outcome during two years in galantamine treated Alzheimer patients
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression
2007) In Neurobiology of Aging(
- Contribution to journal › Article
-
Mark
Three-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.
2007) IPA (International Psychogeriatric Association) 2007 Osaka Silver Congress(
- Contribution to conference › Poster
-
Mark
Activities of Daily Living – Outcome During Three Years in Donepezil Treated Alzheimer Patients.
2007) IPA (International Psychogeriatric Association) 2007 Osaka Silver Congress(
- Contribution to conference › Poster
-
Mark
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly
(
- Contribution to journal › Article
-
Mark
Longitudinal stability of CSF biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
A quick test for cognitive speed: a measure of cognitive speed in dementia with lewy bodies.
(
- Contribution to journal › Article
-
Mark
Effects of Alzheimer's peptide and alpha 1-antichymotrypsin on astrocyte gene expression
(
- Contribution to journal › Article
-
Mark
Prediction of Alzheimer's Disease Using the CSF Abeta42/Abeta40 Ratio in Patients with Mild Cognitive Impairment.
(
- Contribution to journal › Article